1,040
Participants
Start Date
March 6, 2023
Primary Completion Date
March 6, 2027
Study Completion Date
March 6, 2027
personalized surveillance plans (PSP) and personalized aftercare plans (PAP)
The PSP contains decisions on the surveillance trajectory based on individual risks and needs, assessed with the 'Breast Cancer Surveillance Decision Aid' including the INFLUENCE prediction tool. The PAP contains decisions on the aftercare trajectory based on individual needs and preferences and available care resources, which decision-making is supported by a patient decision aid.
Gelre Ziekenhuizen, Apeldoorn
Rijnstate, Arnhem
Jeroen Bosch Ziekenhuis, 's-Hertogenbosch
Bernhoven Ziekenhuis, Uden
Noordwest Ziekenhuisgroep, Alkmaar
Ziekenhuisgroep Twente, Hengelo
Isala Klinieken, Zwolle
Albert Schweitzer Ziekenhuis, Dordrecht
Alrijne Ziekenhuis, Leiderdorp
Haaglanden Medisch Centrum, The Hague
University of Twente
OTHER
Dutch Breast Cancer Association
UNKNOWN
Borstkanker Onderzoek Groep
NETWORK
Netherlands Institute for Health Services Research
UNKNOWN
Comprehensive Cancer Centre The Netherlands
OTHER